Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

132.90 -5.06 (-3.67%)
Streaming Delayed Price Updated: 2:03 PM EDT, Jun 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,466,200
Open 135.26
Bid (Size) 132.89 (4)
Ask (Size) 132.92 (2)
Prev. Close 137.96
Today's Range 131.10 - 135.26
52wk Range 134.09 - 168.11
Shares Outstanding N/A
Dividend Yield 3.91%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why AbbVie and Amgen Are Moving Lower Today
An ultra-low-priced biosimilar may negatively impact both biotechs. 
Via The Motley Fool
AbbVie Unusual Options Activity
 
Via Benzinga

Performance

YTD
-18.15%
-18.15%
1 Month
-13.54%
-13.54%
3 Month
-14.41%
-14.41%
6 Month
-17.55%
-17.55%
1 Year
-9.82%
-9.82%

More News

Read More
2 Dividend Kings on Sale That Are Yielding More Than 4%
Via The Motley Fool
2 Top Dividend Kings to Buy for the Long Haul
Via The Motley Fool
Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
AbbVie Unusual Options Activity
Via Benzinga
Clinical Triumph: MEI Pharma's Voruciclib Demonstrates Encouraging Activity in AML Patients
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,200 Today
Via Benzinga
AbbVie Unusual Options Activity
Via Benzinga
What Does AbbVie's Debt Look Like?
Via Benzinga
Why Ironwood Pharmaceuticals Stock Bumped Higher Today
Via The Motley Fool
VectivBio Stock Catapults 38% After Ironwood Agrees To Buy It For $1 Billion
Via Investor's Business Daily
3 Relatively Safe Stocks to Buy if a Recession Is on the Way
Via The Motley Fool
3 No-Brainer Dividend Stocks to Buy With $1,000 Right Now
Via The Motley Fool
FDA Approves AbbVie/Genmab's Cancer Drug As First Bispecific Antibody For Type Of Lymphoma In Adult Patients
Via Benzinga
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
Via Benzinga
This Is What Whales Are Betting On AbbVie
Via Benzinga
P/E Ratio Insights for AbbVie
Via Benzinga
Peering Into AbbVie's Recent Short Interest
Via Benzinga
Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories
Via Benzinga
One More Quits US Pharma Lobby Group: AstraZeneca Follows Teva, AbbVie Footsteps
Via Benzinga
Pfizer CEO Fires Back On US Drug Pricing Reforms: 'Negotiation with a Gun to Your Head'
Via Benzinga
This Is What Whales Are Betting On AbbVie
Via Benzinga
This Analyst Likes Evolus As 'Top Play In Aesthetics'
Via Benzinga
Is ChatGPT A Better Financial Advisor? We're Going To Find Out
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.